A2A Adenosine Receptor Agonist and PDE4 Inhibition Delays Inflammation but Fails to Reduce Injury in Experimental Obstructive Nephropathy

Publisher： Karger

E-ISSN： 1660-2129|100|3|e113-e123

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.100, Iss.3, 2005-04, pp. : e113-e123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Apoptosis and Bcl-2/Bax in the Development of Tubulointerstitial Fibrosis during Experimental Obstructive Nephropathy

By  

Nephron Experimental Nephrology, Vol. 9, Iss. 2, 2001-01 ,pp. : 71-80

Karger

Access to resources Recommend Favorite

Biology of Congenital Obstructive Nephropathy

By  

Nephron Experimental Nephrology, Vol. 93, Iss. 3, 2004-11 ,pp. : e87-e91

Karger

Access to resources Recommend Favorite

Macrophage Phenotype and Renal Fibrosis in Obstructive Nephropathy

By  

Nephron Experimental Nephrology, Vol. 110, Iss. 1, 2008-08 ,pp. : e31-e36

Karger

Access to resources Recommend Favorite

Tesaglitazar, a Dual Peroxisome Proliferator- Activated Receptor Agonist (PPARα/γ), Improves Metabolic Abnormalities and Reduces Renal Injury in Obese Zucker Rats

By  

Nephron Experimental Nephrology, Vol. 114, Iss. 2, 2009-11 ,pp. : e61-e68

Karger

Access to resources Recommend Favorite

Inflammation in Acute Kidney Injury

By  

Nephron Experimental Nephrology, Vol. 109, Iss. 4, 2008-09 ,pp. : e102-e107

Karger

Access to resources Recommend Favorite